(Press-News.org) Men who start to lose hair at the age of 20 are more likely to develop prostate cancer in later life and might benefit from screening for the disease, according to a new study published online in the cancer journal, Annals of Oncology [1] today.
The French study compared 388 men being treated for prostate cancer with a control group of 281 healthy men and found that those with the disease were twice as likely as the healthy men to have started going bald when they were 20. However, if the men only started to lose their hair when they were 30 or 40, there was no difference in their risk of developing prostate cancer compared to the control group. The study found no association between early hair loss and an earlier diagnosis of prostate cancer, and nor was there any link between the pattern of hair loss and the development of cancer.
Until now there has been conflicting evidence about the link between balding and prostate cancer; this is the first study to suggest a link between going bald at the young age of 20 and the development of prostate cancer in later life.
Professor Philippe Giraud (M.D., PhD), Professor of Radiation Oncology at the Paris Descartes University (Paris, France) and at the European Georges Pompidou Hospital (Paris, France), who led the research, said: "At present there is no hard evidence to show any benefit from screening the general population for prostate cancer. We need a way of identifying those men who are at high risk of developing the disease and who could be targeted for screening and also considered for chemo-prevention using anti-androgenic drugs such as finasteride. Balding at the age of 20 may be one of these easily identifiable risk factors and more work needs to be done now to confirm this."
Androgenic alopecia, sometimes known as male pattern baldness, is common in men, affecting 50% throughout their lifetime. A link has been established between baldness and androgenic hormones, and androgens also play a role in the development and growth of prostate cancer. Finasteride blocks the conversion of testosterone to an androgen called dihydrotestosterone, which is thought to cause hair loss, and the drug is used to treat the condition. It has also been shown to decrease the incidence of prostate cancer.
From September 2004 Prof Giraud and his colleagues asked the men in their study to answer a questionnaire about their personal history of prostate cancer (if any) and to indicate on four pictures any balding patterns that they had at ages 20, 30 and 40. The pictures showed four stages of hair loss: no balding (stage I), frontal hair loss (receding hairline around the temples), vertex hair loss (a round bald patch at the top of the head), or a combination of both types of hair loss (stage IV). The men's doctors were also asked to provide a medical history of their patients, including any diagnosis of prostate cancer, age at diagnosis, stage of the disease and treatment. The study ran for 28 months. The men with prostate cancer were diagnosed with the disease between the ages of 46 and 84.
Dr Michael Yassa (M.D.), currently Assistant Professor at the University of Montreal (Montreal, Canada) and a radiation oncologist at the Maisonneuve-Rosemont Hospital in Montreal, but who previously worked as a radiation oncology Fellow at the European Georges Pompidou Hospital, said: "There were only three men with stage III and none with stage IV hair loss at the age of 20, but the data revealed that any balding at stages II-IV (37 cases and 14 controls) was associated with double the risk of prostate cancer later in life. This trend was lost at ages 30 and 40.
"We were unable to find an association between the type or pattern of hair loss and the development of cancer. This might be due to the very low prevalence of stage III and IV hair loss at the ages of 20 and 30 in our study."
The researchers say the link between baldness and the development of prostate cancer is still unclear. "Further work should be done, both at the molecular level and with larger groups of men, to find the missing link between androgens, early balding and prostate cancer," said Dr Yassa.
###
Notes:
[1] "Male pattern baldness and the risk of prostate cancer". Annals of Oncology. doi:10.1093/annonc/mdq695
[2] The authors declared no conflict of interest.
END
Boston, Mass. - Hospital readmissions are increasingly viewed as an indicator of quality of care. If patients receive appropriate discharge care planning and coordinated outpatient follow-up when leaving the hospital, they should transition safely home without the need to return to the hospital. n a retrospective study of inpatient records at 37 free-standing children's hospitals between 2003 and 2008, nearly 20 percent of admissions and one-quarter of inpatient expenditures ($3.4 billion) were accounted for by a small group (2.9 percent) of patients who were readmitted ...
DALLAS – Feb. 15, 2011 – Breast-cancer patient Kristin Wiginton is the first to be treated at UT Southwestern Medical Center with high-beam radiation using the Accuray CyberKnife System, which offers improved cosmetic results, less radiation exposure to surrounding tissue and a shorter treatment period.
Dr. Wiginton is among 45 participants in a UT Southwestern-based clinical trial – the first of its kind in the Southwest – investigating use of the radiation delivery system for breast cancer. Her post-lumpectomy therapy lasted one-third the duration of a typical radiation ...
Chemical releases, suicide bombers, air and subsurface threats: the U.S. Secret Service needs to be prepared to handle these real-life incidents. Training to respond to such incidents, however, has been more theoretical than practical.
Now, with help from the Department of Homeland Security (DHS) Science & Technology Directorate (S&T), the Secret Service is giving training scenarios a high-tech edge: moving from static tabletop models to virtual kiosks with gaming technology and 3D modeling.
For the past 40 years, a miniature model environment called "Tiny Town" ...
Since 1965, the chances of dying early (under 75) are a fifth higher in the north of England than the south, finds a study published on bmj.com today.
An accompanying editorial says the north-south health divide is now at its widest for 40 years and warns that "the north is being decimated at the rate of a major city every decade."
The north-south health divide in England is well documented and has posed a public health challenge - as well as a political and economic challenge - to successive governments. From 2003 to 2010, the UK government had performance targets ...
Depression can be treated effectively with psychotherapy by mental health nurses with minimal training, according to new preliminary research findings.
The study, led by Durham University's Mental Health Research Centre, shows that patients with severe depression can be treated successfully with behavioural activation – a psychotherapy for depression – by non-specialist mental health staff which could potentially lead to considerable cost-savings for the NHS.
Currently, psychotherapies, such as behavioural activation, are delivered by specialist clinicians and therapists. ...
The genome of the Blackleg fungus, which causes the most damaging disease to canola crops worldwide, has been sequenced for the first time by a team of French and Australian scientists.
Professor Barbara Howlett from the School of Botany at the University of Melbourne, who led the Australian research team, said the discovery was a significant step towards controlling the rampant Blackleg disease.
"The 12,500 genes that constitute the genetic blue print for the fungus Leptosphaeria maculans have been identified and now can be mined to discover how this fungus causes ...
VIDEO:
Three snapshots of the 3-D structure of Mycobacterium tuberculosis' enzyme PriA are combined in this video to show the changes the enzyme is capable of undergoing.
Click here for more information.
In a paper published today in PNAS, scientists from the European Molecular Biology Laboratory (EMBL) in Hamburg, Germany, reveal new insights into the workings of enzymes from a group of bacteria including Mycobacterium tuberculosis, the bacterium that causes tuberculosis. ...
UPTON, NY - Scientists hoping to unravel the mystery of proton spin at the Relativistic Heavy Ion Collider (RHIC, http://www.bnl.gov/rhic/), a 2.4-mile-circumference particle accelerator at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory, have a new tool at their disposal - the first to directly explore how quarks of different types, or "flavors," contribute to the overall spin of the proton. The technique, described in papers just published by RHIC's STAR and PHENIX collaborations in Physical Review Letters, relies on the measurement of particles called ...
Scientists today agree that there are five molecules that are known to affect or cause Alzheimer's disease, which plagues an estimated five million Americans. The potency of these molecules is linked to environmental factors such as diet and lifestyle.
Prof. Daniel Michaelson of Tel Aviv University's Department of Neurobiology at the George S. Wise Faculty of Life Sciences has illuminating news about one of these five molecules — APOE, created by the apolipoprotein E. gene found in all of our bodies.
Prof. Michaelson says APOE comes in two forms, a "good" APOE gene ...
This release is available in French.
Montreal, February 15, 2011 — For many women in violent relationships, leaving is not an option. Yet a woman's arsenal of defenses for resisting violence critically depends on her position within the family and community, according to new research from Concordia University published in the journal Review of Radical Political Economics.
"Women's resistance is often conceptualized only as exit, which is problematic," says study author Stephanie Paterson, a professor in the Concordia University Department of Political Science and ...
